273 related articles for article (PubMed ID: 16195251)
1. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
3. Scaffold attachment factor B (SAFB)1 and SAFB2 cooperatively inhibit the intranuclear mobility and function of ERα.
Hashimoto T; Matsuda K; Kawata M
J Cell Biochem; 2012 Sep; 113(9):3039-50. PubMed ID: 22566185
[TBL] [Abstract][Full Text] [Related]
4. Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes.
Frasor J; Danes JM; Funk CC; Katzenellenbogen BS
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13153-7. PubMed ID: 16141343
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.
Morrison AJ; Herrera RE; Heinsohn EC; Schiff R; Osborne CK
Mol Endocrinol; 2003 Aug; 17(8):1543-54. PubMed ID: 12730327
[TBL] [Abstract][Full Text] [Related]
6. SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells.
Hammerich-Hille S; Kaipparettu BA; Tsimelzon A; Creighton CJ; Jiang S; Polo JM; Melnick A; Meyer R; Oesterreich S
J Biol Chem; 2010 Feb; 285(6):3608-3616. PubMed ID: 19901029
[TBL] [Abstract][Full Text] [Related]
7. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
8. Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis?
Oesterreich S
J Cell Biochem; 2003 Nov; 90(4):653-61. PubMed ID: 14587024
[TBL] [Abstract][Full Text] [Related]
9. Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity.
Debril MB; Dubuquoy L; Feige JN; Wahli W; Desvergne B; Auwerx J; Gelman L
J Mol Endocrinol; 2005 Dec; 35(3):503-17. PubMed ID: 16326836
[TBL] [Abstract][Full Text] [Related]
10. Subcellular dynamics of estrogen-related receptors involved in transrepression through interactions with scaffold attachment factor B1.
Tanida T; Matsuda KI; Uemura T; Yamaguchi T; Hashimoto T; Kawata M; Tanaka M
Histochem Cell Biol; 2021 Sep; 156(3):239-251. PubMed ID: 34129097
[TBL] [Abstract][Full Text] [Related]
11. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
Oesterreich S; Zhang Q; Hopp T; Fuqua SA; Michaelis M; Zhao HH; Davie JR; Osborne CK; Lee AV
Mol Endocrinol; 2000 Mar; 14(3):369-81. PubMed ID: 10707955
[TBL] [Abstract][Full Text] [Related]
13. Scaffold attachment factor B: distribution and interaction with ERα in the rat brain.
Hashimoto T; Kawata M; Hirahara Y; Nishi M; Satoshi I; Matsuda KI
Histochem Cell Biol; 2020 May; 153(5):323-338. PubMed ID: 32086573
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.
Burke LJ; Downes M; Laudet V; Muscat GE
Mol Endocrinol; 1998 Feb; 12(2):248-62. PubMed ID: 9482666
[TBL] [Abstract][Full Text] [Related]
15. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract][Full Text] [Related]
17. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.
Yamaguchi A; Takanashi K
Sci Rep; 2016 Oct; 6():35195. PubMed ID: 27731383
[TBL] [Abstract][Full Text] [Related]
18. Enhancer of rudimentary homologue interacts with scaffold attachment factor B at the nuclear matrix to regulate SR protein phosphorylation.
Drakouli S; Lyberopoulou A; Papathanassiou M; Mylonis I; Georgatsou E
FEBS J; 2017 Aug; 284(15):2482-2500. PubMed ID: 28627136
[TBL] [Abstract][Full Text] [Related]
19. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
20. Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.
Mukhopadhyay NK; Kim J; You S; Morello M; Hager MH; Huang WC; Ramachandran A; Yang J; Cinar B; Rubin MA; Adam RM; Oesterreich S; Di Vizio D; Freeman MR
Oncogene; 2014 Jun; 33(25):3235-45. PubMed ID: 23893242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
